Background Background Because early illness
Because early illness course and outcome may affectthe longcourse and outcome may affectthe longterm outcome of schizophrenia-spectrum term outcome of schizophrenia-spectrum disorders, it is especially importantto disorders, it is especially important to address poor outcome in this early critical address poor outcome in this early critical period. period.
Aims Aims To evaluate whether integrated
To evaluate whether integrated treatment compared with standard treatment compared with standard treatment reduced the proportion of treatment reduced the proportion of patients with poor clinical and social patients with poor clinical and social outcome after1year. outcome after1year.
Method Method Atotal of 547 patients with
Atotal of 547 patients with first-episode psychosis were included in first-episode psychosis were included in the study, 275 randomly assigned to the study, 275 randomly assigned to integrated treatment and 272 to standard integrated treatment and 272 to standard treatment.Measures assessed psychotic treatment.Measures assessed psychotic symptoms and social functioning. symptoms and social functioning.
Results

Results There was a significant
There was a significant beneficial effect of integrated treatment beneficial effect of integrated treatment v.
v. standard treatment on'any poor outcome'. standard treatment on'any poor outcome'. Integrated treatment had a significantly Integrated treatment had a significantly better effect on'any poor outcome' in better effect on'any poor outcome' in patients with schizophrenia compared patients with schizophrenia compared with patients in standard treatment. with patients in standard treatment.
Conclusions Conclusions The integrated treatment
The integrated treatment significantly reduced the proportion of significantly reduced the proportion of patients with poor clinical and social patients with poor clinical and social outcome compared with standard outcome compared with standard treatment. treatment.
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Several long-term studies of course and outSeveral long-term studies of course and outcome of schizophrenia report that about come of schizophrenia report that about 25% of incident and prevalent cases show 25% of incident and prevalent cases show good clinical and social recovery (Bleuler, good clinical and social recovery (Bleuler, 1978; Ciompi, 1980; Shepherd 1978; Ciompi, 1980; Shepherd et al et al, , 1989; Jablensky 1989; Jablensky et al et al, 1992; Hegarty , 1992; Hegarty et al et al, , 1994; Wiersma 1994; Wiersma et al et al, 1998; Harrison , 1998; Harrison et et al al, 2001; Warner, 2004 Warner, ). , 2001 Warner, 2004) . The same studies have found about The same studies have found about 20-25% of the cases experience poor out-20-25% of the cases experience poor outcome (e.g. chronic psychosis, a deteriorating come (e.g. chronic psychosis, a deteriorating course or suicide). course or suicide).
The course of early illness has been The course of early illness has been found to be a strong predictor of the found to be a strong predictor of the course's long-term pattern (Wiersma course's long-term pattern (Wiersma et al et al, , 1998; Harrison 1998; Harrison et al et al, 2001) , and the con-, 2001), and the concept of a 'critical period' has been develcept of a 'critical period' has been developed (Birchwood oped (Birchwood et al et al, 1998) . As early , 1998). As early illness course is an important factor for illness course is an important factor for the long-term course, intervention during the long-term course, intervention during this critical period is considered important this critical period is considered important (McGlashan & Johannessen (McGlashan & Johannessen, 1996; Birch-, 1996; Birchwood wood et al et al, 1998) . The question is whether , 1998). The question is whether intervention can alter the early illness intervention can alter the early illness course, and lead to a lower morbidity course, and lead to a lower morbidity plateau and a less disabling type of course. plateau and a less disabling type of course. Evidence from trials with chronic and Evidence from trials with chronic and mixed populations suggests that there is a mixed populations suggests that there is a positive effect of psychosocial interventions positive effect of psychosocial interventions on clinical and social outcomes, but no on clinical and social outcomes, but no large randomised clinical trial has been large randomised clinical trial has been conducted for first-episode psychosis. conducted for first-episode psychosis.
This paper focuses on prevention of This paper focuses on prevention of poor early outcome. We hypothesised that poor early outcome. We hypothesised that integrated treatment compared with standintegrated treatment compared with standard treatment would reduce the proportion ard treatment would reduce the proportion of patients with a poor clinical and social of patients with a poor clinical and social outcome after 1 year. outcome after 1 year.
METHOD METHOD Sample Sample
The sample comprised patients who fulThe sample comprised patients who fulfilled the following inclusion criteria: age filled the following inclusion criteria: age 18-45 years; clinical diagnoses of schizo-18-45 years; clinical diagnoses of schizophrenia, schizotypal disorder, persistent phrenia, schizotypal disorder, persistent delusional disorder, acute and transient delusional disorder, acute and transient psychotic disorder, schizoaffective disorder, psychotic disorder, schizoaffective disorder, induced delusional disorder, or unspecified induced delusional disorder, or unspecified non-organic psychosis according to non-organic psychosis according to ICD-10 research criteria, based on ICD-10 research criteria, based on Schedules for Clinical Assessment in Schedules for Clinical Assessment in Neuropsychiatry, SCAN version 2.0 and Neuropsychiatry, SCAN version 2.0 and 2.1 (World Health Organization, 1993 , 2.1 (World Health Organization, 1993 , 1998 ; no antipsychotic medication exceed-1998); no antipsychotic medication exceeding 12 weeks of continuous medication; ing 12 weeks of continuous medication; absence of mental retardation and organic absence of mental retardation and organic mental disorder; no psychotic condition mental disorder; no psychotic condition solely due to acute intoxication or a solely due to acute intoxication or a withdrawal state; and written informed withdrawal state; and written informed consent. consent.
A total of 547 patients were included A total of 547 patients were included consecutively from January 1998 to Deconsecutively from January 1998 to December 2000. All patients were randomly cember 2000. All patients were randomly allocated to integrated psychiatric treatallocated to integrated psychiatric treatment or standard treatment. The Copenhament or standard treatment. The Copenhagen Trial Unit carried out randomisation gen Trial Unit carried out randomisation using computer-generated random lists of using computer-generated random lists of patients, whereas in Aarhus, after the initial patients, whereas in Aarhus, after the initial assessment was finished, the researchers assessment was finished, the researchers contacted a secretary, who then drew a lot contacted a secretary, who then drew a lot from among five red and five white lots from among five red and five white lots from a black box. from a black box.
Assessments Assessments
At inclusion, all patients were comprehenAt inclusion, all patients were comprehensively assessed using standardised rating sively assessed using standardised rating instruments, including SCAN 2.0 and 2.1 instruments, including SCAN 2.0 and 2.1 (World Health Organization, 1993 , 1998 , (World Health Organization, 1993 , 1998 al, 1992) . In addition, information was , 1992). In addition, information was collected concerning socio-demographic collected concerning socio-demographic factors (e.g. education, accommodation factors (e.g. education, accommodation and employment status). The same assessand employment status). The same assessment instruments were used at 1-year ment instruments were used at 1-year follow-up, supplemented with copies of follow-up, supplemented with copies of medical records from the preceding year, medical records from the preceding year, whenever available. whenever available.
Researchers with no responsibility for Researchers with no responsibility for treatment carried out all follow-up intertreatment carried out all follow-up interviews. Treatment allocation was not views. Treatment allocation was not concealed from the researchers. concealed from the researchers.
Interrater reliability Interrater reliability
All researchers were trained how to impleAll researchers were trained how to implement the SCAN interview at the World ment the SCAN interview at the World Health Organization collaborating centre Health Organization collaborating centre and trained in SAPS with live interviews. and trained in SAPS with live interviews. The intraclass correlation coefficient (ICC) The intraclass correlation coefficient (ICC) for P.J. and M.A. measuring SAPS global for P.J. and M.A. measuring SAPS global scores was 0.63 (number of cases scores was 0.63 (number of cases¼8). 8). L.P., J.O., G.K., T.C. and A.T. carried out L.P., J.O., G.K., T.C. and A.T. carried out 14 SANS and 12 SAPS reliability interviews 14 SANS and 12 SAPS reliability interviews together. The ICC was 0.54 for the negative together. The ICC was 0.54 for the negative dimension and 0.88 for the positive dimendimension and 0.88 for the positive dimension. sion.
Treatment groups Treatment groups
Integrated treatment Integrated treatment
Three teams were established and trained, Three teams were established and trained, two in Copenhagen and one in Aarhus. two in Copenhagen and one in Aarhus. Each patient was offered integrated treatEach patient was offered integrated treatment for a period of 2 years. The integrated ment for a period of 2 years. The integrated treatment is described below. treatment is described below.
An (1980) was used. A multidisciplinary team including the following: psychiatrist, psyincluding the following: psychiatrist, psychologist, psychiatric nurse, occupational chologist, psychiatric nurse, occupational therapist and social worker, provided the therapist and social worker, provided the integrated treatment. The case-load was integrated treatment. The case-load was 1:10. A primary team member was desig-1:10. A primary team member was designated for each patient and was then nated for each patient and was then responsible for maintaining contact and responsible for maintaining contact and coordinating the treatment within the team coordinating the treatment within the team and across different treatment and support and across different treatment and support facilities. The patients were visited in their facilities. The patients were visited in their homes or other locations in their comhomes or other locations in their community, or they were seen at the office acmunity, or they were seen at the office according to the patients' preference. When cording to the patients' preference. When hospitalised, the patient was visited weekly hospitalised, the patient was visited weekly at the hospital. During in-patient treatment, at the hospital. During in-patient treatment, treatment responsibility was transferred to treatment responsibility was transferred to the hospital. The office hours of the OPUS the hospital. The office hours of the OPUS team were Monday to Friday from team were Monday to Friday from 08.00 h to 17.00 h. All team workers had 08.00 h to 17.00 h. All team workers had a cell telephone with an answering funca cell telephone with an answering function, so that patients could leave a message tion, so that patients could leave a message outside office hours and be sure that the outside office hours and be sure that the team would respond the next morning. A team would respond the next morning. A crisis plan was developed for each patient. crisis plan was developed for each patient. The patients were encouraged to take reThe patients were encouraged to take responsibility for their own affairs as soon sponsibility for their own affairs as soon as possible during the process of recovery. as possible during the process of recovery. If the patient was reluctant to continue If the patient was reluctant to continue treatment, the team tried to motivate the treatment, the team tried to motivate the patient and stayed in contact. patient and stayed in contact.
The team offered medication according The team offered medication according to the low-dose recommendations for to the low-dose recommendations for patients with first-episode psychosis using patients with first-episode psychosis using atypical antipsychotic drugs as first choice. atypical antipsychotic drugs as first choice.
Careful attention was paid to the Careful attention was paid to the patient's adherence to treatment, using patient's adherence to treatment, using psychoeducational methods. psychoeducational methods.
Patients with impaired social skills Patients with impaired social skills assessed by the Disability Assessment assessed by the Disability Assessment Schedule (DAS; Holmes Schedule (DAS; Holmes et al et al, 1982) were , 1982) were offered social skills training with focus on offered social skills training with focus on medication, coping with symptoms, medication, coping with symptoms, conversation, problem-solving and conflictconversation, problem-solving and conflictsolving skills in a group with a maximum solving skills in a group with a maximum of six patients and two therapists. The of six patients and two therapists. The patients who were unable to work in a patients who were unable to work in a group were offered individual training. group were offered individual training. Patients who did not need social Patients who did not need social skills training received individual skills training received individual psychoeducation. psychoeducation. s 9 9 s 9 9 
Data analysis Data analysis
Pearson Pearson w w 2 2 was used as appropriate to test was used as appropriate to test for statistically significant differences for statistically significant differences between treatment groups at baseline. Level between treatment groups at baseline. Level of significance was 0.05. With logistical of significance was 0.05. With logistical regression analysis, the odds ratio (OR) regression analysis, the odds ratio (OR) for treatment effect was calculated with for treatment effect was calculated with the baseline value of the scale included as the baseline value of the scale included as a covariate. All statistical analysis was a covariate. All statistical analysis was performed using the Statistical Package performed using the Statistical Package for the Social Sciences, version 11.0 for for the Social Sciences, version 11.0 for Windows. Outcome measures were anaWindows. Outcome measures were analysed lysed according to intention-to-treat according to intention-to-treat principles. principles.
Using the formula described by Pocock Using the formula described by Pocock (1996), we found that 262 patients in each (1996), we found that 262 patients in each treatment condition were necessary in order treatment condition were necessary in order to detect a difference at 1-year follow-up to detect a difference at 1-year follow-up between 10 and 20% in less frequent outbetween 10 and 20% in less frequent outcome measures, with a significance level come measures, with a significance level of 0.05 and 90% power. of 0.05 and 90% power.
Representation Representation
The number of patients included in the proThe number of patients included in the project corresponded to 90% in Aarhus and ject corresponded to 90% in Aarhus and 63% in Copenhagen of all patients regis-63% in Copenhagen of all patients registered as having a first-episode psychosis in tered as having a first-episode psychosis in the schizophrenia spectrum in the same the schizophrenia spectrum in the same catchment areas. In both centres, patients catchment areas. In both centres, patients included in the trial were significantly included in the trial were significantly younger compared with those in the younger compared with those in the register, and significantly more were register, and significantly more were diagnosed with schizophrenia. diagnosed with schizophrenia.
Outcome measures Outcome measures
We defined 'poor outcome' for all the variWe defined 'poor outcome' for all the variables included in the analysis: any global ables included in the analysis: any global score of SAPS or SANS over 3; substance score of SAPS or SANS over 3; substance misuse or dependence present; GAF-S misuse or dependence present; GAF-S (Symptom) and GAF-D (Disability) scores (Symptom) and GAF-D (Disability) scores below 30; being homeless or living in shelbelow 30; being homeless or living in sheltered or supervised accommodation; no tered or supervised accommodation; no work and not in education during the prework and not in education during the preceding year. Finally, death was included ceding year. Finally, death was included as a poor outcome. as a poor outcome.
In addition, we constructed a global In addition, we constructed a global measure: 'any poor outcome': any measure: 'any poor outcome': any psychotic or negative global scores of SANS psychotic or negative global scores of SANS or SAPS 'marked' or 'severe', or substance or SAPS 'marked' or 'severe', or substance misuse or dependence present, or GAF misuse or dependence present, or GAF scores under 30, or homeless or living in scores under 30, or homeless or living in sheltered or supervised accommodation, sheltered or supervised accommodation, or no work and not in education. This or no work and not in education. This was based on the assumption that poor outwas based on the assumption that poor outcome in any of the variables is considered come in any of the variables is considered disabling. disabling.
RESULTS RESULTS
Main baseline characteristics of the cohort Main baseline characteristics of the cohort are shown in Table 1 . No statistical are shown in Table 1 . No statistical differences were found between treatment differences were found between treatment groups at baseline in either clinical or groups at baseline in either clinical or socio-demographic characteristics. socio-demographic characteristics. Figure 1 shows the flow of patients dur- Figure 1 shows the flow of patients during the first year of follow-up. A total of ing the first year of follow-up. A total of 419 patients were interviewed at 1-year 419 patients were interviewed at 1-year follow-up. More patients in the integrated follow-up. More patients in the integrated treatment group (83% treatment group (83% v.
v. 71% in the stand-71% in the standard treatment group) participated in the ard treatment group) participated in the follow-up interview. Analysis has shown follow-up interview. Analysis has shown that no clinical or basic socio-demographic that no clinical or basic socio-demographic baseline characteristics were associated baseline characteristics were associated with participation after 1 year except that with participation after 1 year except that more interviewed patients in both groups more interviewed patients in both groups had 11-13 years of education compared had 11-13 years of education compared with those not interviewed. with those not interviewed. Table 2 summarises outcome variables  Table 2 summarises outcome variables after 1 year regarding poor outcome. The after 1 year regarding poor outcome. The number of patients varies for the different number of patients varies for the different variables because all relevant information variables because all relevant information concerning socio-demographic and psychoconcerning socio-demographic and psychopathological status at 1 year was recorded pathological status at 1 year was recorded from medical records, if possible, for from medical records, if possible, for patients who were not re-interviewed. patients who were not re-interviewed. 'Any poor outcome' is based on patients 'Any poor outcome' is based on patients attending the 1-year interview. There were attending the 1-year interview. There were significant differences favouring integrated significant differences favouring integrated treatment in the proportion of patients with treatment in the proportion of patients with high psychotic global scores (OR high psychotic global scores (OR¼0.35, 0.35, 95% CI 0.2-0.6, 95% CI 0.2-0.6, P P¼0.001) and high nega-0.001) and high negatives global scores (OR tives global scores (OR¼0.49, 95% CI 0.3-0.49, 95% CI 0.3-0.8, 0.8, P P¼0.002). Significantly fewer patients 0.002). Significantly fewer patients receiving integrated treatment had GAF-S receiving integrated treatment had GAF-S scores below 30 (OR scores below 30 (OR¼0.55 95% CI 0.3-0.55 95% CI 0.3-1.0, 1.0, P P¼0.04), and fewer were homeless or 0.04), and fewer were homeless or living in sheltered accommodation living in sheltered accommodation (OR (OR¼0.53, 95% CI 0.3-0.9, 0.53, 95% CI 0.3-0.9, P P¼0.02) or 0.02) or had no work (OR had no work (OR¼0.31, 95% CI 0.2-0.5, 0.31, 95% CI 0.2-0.5, P P¼0.01). Significantly fewer patients pre-0.01). Significantly fewer patients presented comorbidity for drug or alcohol missented comorbidity for drug or alcohol misuse or dependence in the intervention group use or dependence in the intervention group at 1-year follow-up (OR at 1-year follow-up (OR¼0.54, 95% CI 0.54, 95% CI 0.3-0.9, 0.3-0.9, P P¼0.03). Three patients in the 0.03). Three patients in the standard group and one patient in the intestandard group and one patient in the integrated treatment had died. grated treatment had died.
In general, 64% of all the patients had In general, 64% of all the patients had 'any poor outcome' after 1 year. There 'any poor outcome' after 1 year. There was a significant beneficial effect of intewas a significant beneficial effect of integrated treatment grated treatment v.
v. standard treatment on standard treatment on 'any poor outcome' (OR 'any poor outcome' (OR¼0.50, 95% CI 0.50, 95% CI 0.3-0.8, 0.3-0.8, P P¼0.001). 0.001).
s1 0 0 s1 0 0 Flowchart of patients in the OPUS trial during the first year of follow-up.
IM P ROV ING 1 -Y E A R OU TCOME IN F I R S T-E P I S OD E P S YCHOS I S I M P ROV IN G 1 -Y E A R OU TCOM E IN F I R S T-E P I S OD E P S YCHOS I S
s1 0 1 s1 0 1 Table 2  Table 2 Symptoms and social disability at 1-year follow-up: integrated treatment (IT) and standard treatment (ST) Symptoms and social disability at 1-year follow-up: integrated treatment (IT) and standard treatment (ST) (8) 3 (8) 5 (12) 5 (12) 17 (7) 17 (7) 22 (9) 22 ( 107 (42) 107 (42) 121 (53) 121 (53) (32) 13 (32) 13 (41) 13 ( 
130 (57) 130 (57) 140 (73) 140 (73) (54) 20 (54) 16 (62) 16 ( (44) 17 (44) 22 (52) 22 (52) 
DISCUSSION DISCUSSION
To our knowledge, the present study is the To our knowledge, the present study is the first randomised controlled trial of intefirst randomised controlled trial of integrated treatment grated treatment v.
v. standard treatment for standard treatment for first-episode psychosis. The findings first-episode psychosis. The findings suggest that integrated treatment improved suggest that integrated treatment improved the early illness course, and that this was the early illness course, and that this was most marked in patients with schizomost marked in patients with schizophrenia. High levels of psychotic and negaphrenia. High levels of psychotic and negative symptom scores were less prevalent in tive symptom scores were less prevalent in patients receiving integrated treatment after patients receiving integrated treatment after 1 year. Better adherence to antipsychotic 1 year. Better adherence to antipsychotic medication in the integrated treatment medication in the integrated treatment group could explain these results. However, group could explain these results. However, no significant differences were found no significant differences were found between treatment groups in antipsychotic between treatment groups in antipsychotic medication (Thorup medication (Thorup et al et al, 2005 ). Social , 2005 . Social outcome data were also better for inteoutcome data were also better for integrated treatment; and for the global meagrated treatment; and for the global measure 'any poor outcome', the significantly sure 'any poor outcome', the significantly better effect of integrated treatment on better effect of integrated treatment on poor outcome is replicated. Thus, the findpoor outcome is replicated. Thus, the findings supported the hypothesis that patients ings supported the hypothesis that patients on standard treatment had poorer outcome. on standard treatment had poorer outcome.
There are some limitations to the study. There are some limitations to the study. The randomisation procedure used in The randomisation procedure used in Aarhus is not optimal because it does not Aarhus is not optimal because it does not offer the same protection against unmaskoffer the same protection against unmasking as the computerised model used in Coing as the computerised model used in Copenhagen. However, it does not seem to penhagen. However, it does not seem to affect the results. affect the results.
Blinding of the assessors to treatment Blinding of the assessors to treatment allocation would have been optimal, but allocation would have been optimal, but this was not judged to be possible in this this was not judged to be possible in this kind of trial. There is a potential risk of bias kind of trial. There is a potential risk of bias due to skewed attrition. We have found a due to skewed attrition. We have found a higher proportion living independently at higher proportion living independently at 1 year among participants compared with 1 year among participants compared with non-participants in the 1-year follow-up non-participants in the 1-year follow-up interview, and the finding that patients interview, and the finding that patients with higher education were more likely to with higher education were more likely to attend follow-up interviews might indicate attend follow-up interviews might indicate that the group not participating had a that the group not participating had a worse outcome. This could bias the worse outcome. This could bias the analyses toward the integrated treatment. analyses toward the integrated treatment. This is especially important when focus is This is especially important when focus is on poor outcome, as it might be expected on poor outcome, as it might be expected that patients with the poorest outcome that patients with the poorest outcome would be the ones to drop out of the trial. would be the ones to drop out of the trial. Short-term course is found to be an importShort-term course is found to be an important predictor of long-term outcome. The reant predictor of long-term outcome. The results of the present study suggest that sults of the present study suggest that integrated treatment at this early stage of integrated treatment at this early stage of the illness course might have an effect in the illness course might have an effect in preventing patients from experiencing the preventing patients from experiencing the poorest outcome, and thus perhaps affect poorest outcome, and thus perhaps affect the long-term course of the illness. This the long-term course of the illness. This emphasises the importance of intervention emphasises the importance of intervention in the early period. in the early period. There was a suboptimal randomisation procedure in Aarhus.
& & There was a potential risk of bias due to skewed attrition. There was a potential risk of bias due to skewed attrition.
